Current Genmab AS forecasts and price targets in November 2026
Ø Analyst Price Targets
50.83 USD
+0.45 %
Median
47.50 USD
-6.13 %
Max
70.00 USD
Min
40.00 USD
Last Price
50.60 USD
Buy
20
Hold
2
Sell
3
The average target price for Genmab AS is 50.83 USD. (+0.45 % above the current price)
The median price target of Genmab AS is 47.50 USD.
Stock analysts from many renowned investment banks are closely examining the Genmab AS stock. They conclude their professional Genmab AS stock analyses with a clear recommendation for the Genmab AS stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-11-01 | 20 | 2 | 3 | 50.83 USD |
| 2026-10-01 | 22 | 3 | 1 | 38.60 USD |
| 2026-09-01 | 22 | 3 | 2 | 38.60 USD |
| 2026-08-01 | 21 | 3 | 2 | 38.60 USD |
| 2026-07-01 | 19 | 4 | 2 | — |
| 2026-06-01 | 19 | 4 | 2 | — |
Genmab AS Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Genmab AS in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 4.47 B USD | 766.00 M USD | 1.14 USD |
| 2027e | 5.41 B USD | 998.00 M USD | 1.48 USD |
| 2028e | 6.90 B USD | 1.66 B USD | 2.47 USD |